Alnylam Pharmaceuticals
ALNY
#541
Rank
NZ$74.69 B
Marketcap
NZ$565.38
Share price
0.28%
Change (1 day)
14.69%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company